TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

LIFE MOLECULAR

NeurologyCardiovascularOncology
Pharma

LIFE MOLECULAR is a pharmaceutical company focused on Neurology, Cardiovascular, Oncology. Key products include NEURACEQ.

2014
Since
1
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

NEURACEQ
florbetaben f-18
CNS
2 indications · 2014

Recent Activity

NEURACEQ 2025-06-23
Labeling
NEURACEQ 2025-06-23
Efficacy
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 65%
1 drugs Phase 3: 1 Phase 1: 1
Cardiovascular 29%
0 drugs Phase 3: 1 Phase 1: 1
Oncology 6%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

GE HEALTHCARE specialty
Neurology, Cardiovascular, Oncology
Novo Nordisk big-pharma
Oncology, Cardiovascular, Neurology
Novartis big-pharma
Oncology, Cardiovascular
AZURITY specialty
Cardiovascular, Oncology, Neurology
Merck big-pharma
Oncology, Cardiovascular